NO971261L - Kinoksalin-derivater nyttige innen terapi - Google Patents
Kinoksalin-derivater nyttige innen terapiInfo
- Publication number
- NO971261L NO971261L NO971261A NO971261A NO971261L NO 971261 L NO971261 L NO 971261L NO 971261 A NO971261 A NO 971261A NO 971261 A NO971261 A NO 971261A NO 971261 L NO971261 L NO 971261L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- alkyl
- therapy
- derivatives useful
- quinoxaline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9419318A GB9419318D0 (en) | 1994-09-24 | 1994-09-24 | Therapeutic agents |
PCT/EP1995/003559 WO1996009295A1 (en) | 1994-09-24 | 1995-09-08 | Quinoxaline derivatives useful in therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971261D0 NO971261D0 (no) | 1997-03-19 |
NO971261L true NO971261L (no) | 1997-05-05 |
Family
ID=10761869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971261A NO971261L (no) | 1994-09-24 | 1997-03-19 | Kinoksalin-derivater nyttige innen terapi |
Country Status (28)
Country | Link |
---|---|
US (1) | US5852016A (hu) |
EP (1) | EP0783495B1 (hu) |
JP (1) | JP2986920B2 (hu) |
KR (1) | KR970706261A (hu) |
CN (1) | CN1158610A (hu) |
AT (1) | ATE213731T1 (hu) |
AU (1) | AU688591B2 (hu) |
BR (1) | BR9504132A (hu) |
CA (1) | CA2200742C (hu) |
CO (1) | CO4410336A1 (hu) |
CZ (1) | CZ85797A3 (hu) |
DE (1) | DE69525633T2 (hu) |
DK (1) | DK0783495T3 (hu) |
ES (1) | ES2171553T3 (hu) |
FI (1) | FI971193A (hu) |
GB (1) | GB9419318D0 (hu) |
HU (1) | HUT77734A (hu) |
IL (2) | IL115334A0 (hu) |
MX (1) | MX9702259A (hu) |
NO (1) | NO971261L (hu) |
NZ (1) | NZ292922A (hu) |
PE (1) | PE47596A1 (hu) |
PL (1) | PL319405A1 (hu) |
PT (1) | PT783495E (hu) |
RU (1) | RU2135484C1 (hu) |
TR (1) | TR199501158A2 (hu) |
WO (1) | WO1996009295A1 (hu) |
ZA (1) | ZA958023B (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY132385A (en) * | 1995-08-31 | 2007-10-31 | Novartis Ag | 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
DK0784973T3 (da) * | 1995-10-10 | 2002-03-18 | Pfizer | Quinoxalinderivater til behandling af tinnitus |
GB9604400D0 (en) * | 1996-03-01 | 1996-05-01 | Pfizer Ltd | Compounds useful in therapy |
US6191134B1 (en) | 1996-06-05 | 2001-02-20 | Warner-Lambert Company | Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonists |
US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
NZ336971A (en) * | 1997-02-18 | 2000-10-27 | American Home Prod | 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones useful as dopamine agonists |
TW526195B (en) | 1997-06-10 | 2003-04-01 | Novartis Ag | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use |
GB0310881D0 (en) * | 2003-05-12 | 2003-06-18 | Merck Sharp & Dohme | Pharmaceutical formulation |
US10208000B2 (en) | 2015-12-16 | 2019-02-19 | University Of Kentucky Research Foundation | Eis inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE572852C (de) * | 1931-03-08 | 1933-03-24 | Willy Messerschmitt Dipl Ing | Verfahren zur Herstellung von Flugzeugtragfluegeln mit trapezfoermigem Grundriss |
DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
US5283244A (en) * | 1990-11-06 | 1994-02-01 | Yamanouchi Pharmaceutical Co., Ltd. | Fused pyrazine derivatives |
DE4123106A1 (de) * | 1991-07-09 | 1993-01-14 | Schering Ag | Arzneimittel zur behandlung von entzugssymptomen |
PT101004B (pt) * | 1991-10-26 | 1999-10-29 | Schering Ag | Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem |
DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
DE4439493A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
DE4439492A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
US5614508A (en) * | 1995-06-07 | 1997-03-25 | Warner-Lambert Company | Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
-
1994
- 1994-09-24 GB GB9419318A patent/GB9419318D0/en active Pending
-
1995
- 1995-09-08 PT PT95932021T patent/PT783495E/pt unknown
- 1995-09-08 CA CA002200742A patent/CA2200742C/en not_active Expired - Fee Related
- 1995-09-08 NZ NZ292922A patent/NZ292922A/en unknown
- 1995-09-08 HU HU9800754A patent/HUT77734A/hu unknown
- 1995-09-08 MX MX9702259A patent/MX9702259A/es not_active IP Right Cessation
- 1995-09-08 AU AU35232/95A patent/AU688591B2/en not_active Ceased
- 1995-09-08 KR KR1019970701887A patent/KR970706261A/ko active IP Right Grant
- 1995-09-08 CZ CZ97857A patent/CZ85797A3/cs unknown
- 1995-09-08 EP EP95932021A patent/EP0783495B1/en not_active Expired - Lifetime
- 1995-09-08 CN CN95195253A patent/CN1158610A/zh active Pending
- 1995-09-08 RU RU97107018A patent/RU2135484C1/ru active
- 1995-09-08 ES ES95932021T patent/ES2171553T3/es not_active Expired - Lifetime
- 1995-09-08 PL PL95319405A patent/PL319405A1/xx unknown
- 1995-09-08 DK DK95932021T patent/DK0783495T3/da active
- 1995-09-08 DE DE69525633T patent/DE69525633T2/de not_active Expired - Fee Related
- 1995-09-08 WO PCT/EP1995/003559 patent/WO1996009295A1/en active IP Right Grant
- 1995-09-08 AT AT95932021T patent/ATE213731T1/de not_active IP Right Cessation
- 1995-09-08 US US08/809,337 patent/US5852016A/en not_active Expired - Fee Related
- 1995-09-08 JP JP8510561A patent/JP2986920B2/ja not_active Expired - Fee Related
- 1995-09-18 IL IL11533495A patent/IL115334A0/xx unknown
- 1995-09-20 PE PE1995279512A patent/PE47596A1/es not_active Application Discontinuation
- 1995-09-22 ZA ZA958023A patent/ZA958023B/xx unknown
- 1995-09-22 BR BR9504132A patent/BR9504132A/pt not_active IP Right Cessation
- 1995-09-22 CO CO95043930A patent/CO4410336A1/es unknown
- 1995-09-22 TR TR95/01158A patent/TR199501158A2/xx unknown
-
1997
- 1997-03-19 NO NO971261A patent/NO971261L/no unknown
- 1997-03-21 FI FI971193A patent/FI971193A/fi unknown
-
1998
- 1998-09-07 IL IL12610498A patent/IL126104A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR9504132A (pt) | 1996-08-06 |
MX9702259A (es) | 1997-06-28 |
US5852016A (en) | 1998-12-22 |
GB9419318D0 (en) | 1994-11-09 |
TR199501158A2 (tr) | 1997-02-21 |
EP0783495B1 (en) | 2002-02-27 |
CN1158610A (zh) | 1997-09-03 |
PT783495E (pt) | 2002-07-31 |
AU688591B2 (en) | 1998-03-12 |
RU2135484C1 (ru) | 1999-08-27 |
ATE213731T1 (de) | 2002-03-15 |
IL115334A0 (en) | 1995-12-31 |
WO1996009295A1 (en) | 1996-03-28 |
FI971193A (fi) | 1997-05-21 |
NZ292922A (en) | 1998-07-28 |
ZA958023B (en) | 1997-03-24 |
CO4410336A1 (es) | 1997-01-09 |
KR970706261A (ko) | 1997-11-03 |
CA2200742A1 (en) | 1996-03-28 |
CZ85797A3 (cs) | 1998-09-16 |
JPH09511526A (ja) | 1997-11-18 |
CA2200742C (en) | 2001-09-11 |
NO971261D0 (no) | 1997-03-19 |
AU3523295A (en) | 1996-04-09 |
PE47596A1 (es) | 1996-11-12 |
ES2171553T3 (es) | 2002-09-16 |
IL126104A0 (en) | 1999-05-09 |
DK0783495T3 (da) | 2002-04-22 |
EP0783495A1 (en) | 1997-07-16 |
FI971193A0 (fi) | 1997-03-21 |
JP2986920B2 (ja) | 1999-12-06 |
HUT77734A (hu) | 1998-07-28 |
PL319405A1 (en) | 1997-08-04 |
DE69525633T2 (de) | 2002-08-08 |
DE69525633D1 (de) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69429078D1 (de) | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung | |
BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
CY1107391T1 (el) | Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις | |
DK0574313T3 (da) | 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme | |
ES2181853T3 (es) | Tratamiento del tinnitus empleando agentes neuroprotectores. | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
SE9703414D0 (sv) | New compounds | |
TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
NO971261L (no) | Kinoksalin-derivater nyttige innen terapi | |
DE69525327D1 (de) | Anthracyclin-derivate | |
ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
HRP950437B1 (en) | N-substituted azabicycloheptane derivatives, their production and use | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
NO20003138L (no) | Ny anvendelse av lokalanestetika mot vaskulære hodepiner | |
DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
DE69619088D1 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
DE50100396D1 (de) | (+)- und (-)-2-Cyclododecylpropanol und (+)- und (-)-2-Cyclododecylpropionsäure sowie deren Herstellung und Verwendung | |
DK0662081T3 (da) | Ureidoacetamidderivater, deres fremstilling og lægemidler indeholdende disse derivater |